{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:46:21Z","timestamp":1782279981572,"version":"3.54.5"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Colon adenocarcinoma (COAD) shows marked clinical heterogeneity, and robust biomarkers with mechanistic relevance are still needed for prognostic stratification.\n                      <jats:italic>RBMS3<\/jats:italic>\n                      has been implicated in tumor biology, but its pan-cancer significance, prognostic value in COAD, and regulatory mechanisms remain insufficiently defined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed integrated analyses of The Cancer Genome Atlas pan-cancer and COAD cohorts, followed by external validation in GEO datasets. Prognostic associations were evaluated by Cox and Kaplan-Meier analyses, and clinicopathological relevance was assessed in TCGA-COAD. A prognostic nomogram combining\n                      <jats:italic>RBMS3<\/jats:italic>\n                      and clinical variables was constructed. Single-cell RNA-seq analysis was used to characterize\n                      <jats:italic>RBMS3<\/jats:italic>\n                      -associated functional programs.\n                      <jats:italic>In vitro<\/jats:italic>\n                      experiments in HCT116 cell and THP-1-derived M2 macrophage co-culture systems were conducted to validate ferroptosis-related effects and upstream\n                      <jats:italic>STAT3<\/jats:italic>\n                      -dependent regulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>RBMS3<\/jats:italic>\n                      was significantly dysregulated across multiple tumor types and showed prognostic relevance in pan-cancer analysis, with a prominent adverse survival association in COAD. GEO cohorts confirmed decreased\n                      <jats:italic>RBMS3<\/jats:italic>\n                      expression in tumor samples relative to normal controls, and low\n                      <jats:italic>RBMS3<\/jats:italic>\n                      expression was associated with unfavorable prognosis, supporting its tumor-suppressive prognostic role. In TCGA-COAD,\n                      <jats:italic>RBMS3<\/jats:italic>\n                      expression correlated with T stage and pathological stage, and integration of\n                      <jats:italic>RBMS3<\/jats:italic>\n                      with staging factors improved prognostic stratification in a nomogram model. Single-cell analysis showed enrichment of ferroptosis-related pathways in\n                      <jats:italic>RBMS3<\/jats:italic>\n                      -positive tumor cells. Functionally,\n                      <jats:italic>RBMS3<\/jats:italic>\n                      overexpression in HCT116 cells reduced viability, decreased GPX4, increased\n                      <jats:italic>ACSL4<\/jats:italic>\n                      , and elevated intracellular Fe ion levels, indicating molecular features consistent with enhanced ferroptotic sensitivity. Mechanistically, M2 macrophages suppressed\n                      <jats:italic>RBMS3<\/jats:italic>\n                      expression in tumor cells with concomitant\n                      <jats:italic>STAT3<\/jats:italic>\n                      activation, while pharmacological\n                      <jats:italic>STAT3<\/jats:italic>\n                      inhibition partially restored\n                      <jats:italic>RBMS3<\/jats:italic>\n                      expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>RBMS3<\/jats:italic>\n                      is a clinically relevant prognostic biomarker in COAD and is linked to ferroptosis-associated tumor-cell programs. The M2 macrophage-\n                      <jats:italic>STAT3<\/jats:italic>\n                      -\n                      <jats:italic>RBMS3<\/jats:italic>\n                      axis provides a mechanistic connection between the immune microenvironment and tumor intrinsic regulation, highlighting\n                      <jats:italic>RBMS3<\/jats:italic>\n                      as a potential target for prognostic modeling and translational intervention in COAD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2026.1872659","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:46:10Z","timestamp":1782276370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RBMS3 promotes ferroptosis in colorectal cancer and is suppressed by M2 tumor-associated macrophages via STAT3 activation"],"prefix":"10.3389","volume":"13","author":[{"given":"Haiying","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Shuai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Beijing Rehabilitation Hospital of Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1038\/s41388-021-02030-x","article-title":"RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA","volume":"40","author":"Block","year":"2021","journal-title":"Oncogene"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2026.01.008","article-title":"Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications","author":"Chen","year":"2026","journal-title":"Trends Mol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e44636","DOI":"10.1371\/journal.pone.0044636","article-title":"RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-026-03993-x","article-title":"ACSL4 as a potential ferroptosis target in hepatocellular carcinoma: from mechanisms to implications","author":"Cui","year":"2026","journal-title":"Eur. J. Med. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2326-6066.CIR-25-1073","article-title":"DDR1 promotes immune evasion in colorectal cancer by orchestrating IL-33-Mediated M2-like polarization of tumor-associated macrophages","volume":"14","author":"Duan","year":"2026","journal-title":"Cancer Immunol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1158\/0008-5472.CAN-10-4291","article-title":"Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00018-026-06183-4","article-title":"SLC25A21 promotes ferroptosis by inducing mitochondrial GPX4 deficiency in colorectal cancer","volume":"83","author":"Liu","year":"2026","journal-title":"Cell. Mol. Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.7150\/jca.86572","article-title":"RBMS3, a downstream target of AMPK, exerts inhibitory effects on invasion and metastasis of lung cancer","volume":"14","author":"Lv","year":"2023","journal-title":"J. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10722","DOI":"10.1038\/s41598-025-95432-w","article-title":"Deciphering the tumor-suppressive role of RBMS3 in lung adenocarcinoma through genomic insights into prognosis and mechanisms","volume":"15","author":"Lv","year":"2025","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/ph19020252","article-title":"Ferroptosis as a novel therapeutic strategy to overcome multidrug resistance in colorectal cancer","volume":"19","author":"Mahemuti","year":"2026","journal-title":"Pharm. (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/19768354.2024.2442401","article-title":"Parvimonas micra-polarized M2-like tumor-associated macrophages accelerate colorectal cancer development via IL-8 secretion","volume":"29","author":"Nguyen","year":"2025","journal-title":"Anim. Cells Syst. Seoul."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e70196","DOI":"10.1002\/cbf.70196","article-title":"Comprehensive overview of therapeutic strategies in Colon cancer: Chemotherapy, targeted therapy, and immunotherapy","volume":"44","author":"Sulaiman","year":"2026","journal-title":"Cell. Biochem. Funct."},{"key":"B13","doi-asserted-by":"publisher","first-page":"103883","DOI":"10.1016\/j.medengphy.2022.103883","article-title":"Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer","volume":"110","author":"Wang","year":"2022","journal-title":"Med. Eng. Phys."},{"key":"B14","doi-asserted-by":"publisher","first-page":"112540","DOI":"10.1016\/j.cellsig.2026.112540","article-title":"RBMS3 synergistically suppresses ovarian cancer progression at the post-transcriptional level by destabilizing ELAVL1 mRNA and inhibiting UPF1 methylation","volume":"144","author":"Wang","year":"","journal-title":"Cell. Signal"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103202","DOI":"10.1016\/j.tice.2025.103202","article-title":"Lactic acid inhibits ferroptosis and promotes M2 macrophage polarization in colon cancer via GPX4 regulation","volume":"98","author":"Wang","year":"","journal-title":"Tissue Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/or.2020.7594","article-title":"Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma","volume":"44","author":"Wu","year":"2020","journal-title":"Oncol. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1007\/s12013-025-01859-3","article-title":"Function and mechanism of the RNA-binding protein RBMS3 in malignant tumours","volume":"83","author":"Xin","year":"2025","journal-title":"Cell. Biochem. Biophys."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-49584-y","article-title":"A multimodal approach integrating NK cell-associated gene signatures and pathomics to predict colon adenocarcinoma prognosis","author":"Yang","year":"2026","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e30603","DOI":"10.1016\/j.heliyon.2024.e30603","article-title":"Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration","volume":"10","author":"Yin","year":"2024","journal-title":"Heliyon"},{"key":"B20","first-page":"2679","article-title":"Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer","volume":"6","author":"Zhang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e70705","DOI":"10.1096\/fj.202500906R","article-title":"Metformin enhances PD-L1 inhibitor efficacy in ovarian cancer by modulating the immune microenvironment and RBMS3 expression","volume":"39","author":"Zhang","year":"2025","journal-title":"FASEB J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100968","DOI":"10.1016\/j.repbio.2024.100968","article-title":"Metformin-induced RBMS3 expression enhances ferroptosis and suppresses ovarian cancer progression","volume":"25","author":"Zhao","year":"2025","journal-title":"Reprod. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"151724","DOI":"10.1016\/j.ijbiomac.2026.151724","article-title":"Tumor-derived JAG2 programs macrophages via NOTCH3 to drive perineural invasion in colorectal cancer","volume":"358","author":"Zhao","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41388-025-03335-x","article-title":"RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma","volume":"44","author":"Zhu","year":"2025","journal-title":"Oncogene"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1872659\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:46:16Z","timestamp":1782276376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1872659\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":24,"alternative-id":["10.3389\/fmolb.2026.1872659"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1872659","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1872659"}}